report cover1

Global Drug-Device Combination Products Market “(By Products: Auto-injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens, and Others), (By End-user: Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers, and Others) (By Application: Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, and Others), (By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)” – Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the “Global Drug-Device Combination Products Market.” The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.

Global Drug-Device Combination Products Market Analysis

According to cognizance market research, the Global Drug-Device Combination Products Market was valued at US$ 123.9 billion in 2022 and is anticipated to reach US$ 190.1 billion by the end of 2030 with a CAGR of 5.5% from 2023 to 2030.

drug device combination products market

What is the Global Drug-Device Combination Products Market?

Drug delivery systems play a crucial role in various medical treatments. Among them, drug-device combination products consist of pharmaceutical substances combined with medical devices designed to efficiently deliver the drug to the specific location within the patient’s body. Examples of these products include prefilled medication delivery systems like metered dose inhalers, insulin injector pens, and syringes, as well as surgical trays containing drapes and anesthetic swabs. Additionally, you’ll find innovative combinations like monoclonal antibodies paired with therapeutic drugs, pacing leads featuring steroid-coated tips, catheters with antimicrobial coatings, and first-aid kits stocked with bandages and gauze.

In accordance with Article 117 of the Medical Equipment Regulation, manufacturers are obligated to obtain a Notified Body Opinion (NBOP) before releasing drug-device combination products as integral devices, marketing them as “medicinal products.” The Notified Body carefully assesses compliance with the relevant General Performance and Safety Standards (GSPR) and provides the manufacturer with an NBOP Report to be included in the Marketing Authorization Application (MAA).

As the prevalence of chronic diseases continues to rise, and technology continually advances, the market for drug-device combinations is expanding. Nevertheless, this growth may face challenges and limitations due to regulatory constraints. While collaborations among major market players offer opportunities for innovation, the stringent regulatory environment poses a potential barrier to the global expansion of the drug-device combination market.

Global Drug-Device Combination Products Market Outlook

The increasing prevalence of chronic illnesses and the desire for innovative approaches to disease treatment are key factors driving the adoption of medical device combination products worldwide. These products offer numerous benefits for patients suffering from conditions such as spinal cord injuries, diabetes, rheumatoid arthritis, hepatitis, multiple sclerosis, heart disease, cancer, cerebral palsy, and anemia. Some of these benefits include reduced side effects, regulated medication delivery, improved patient compliance, and focused drug delivery.

Inhalers, autoinjectors, pre-filled pens, pre-filled nebulizers, pre-filled syringes, and transdermal patches are among the products that have seen increased usage due to their associated advantages, such as decreased pain levels, shorter hospital stays, improved patient outcomes, and overall healthcare cost-effectiveness. Additional benefits include improved tolerance levels, simpler dosage regimens, and enhanced symptomatic and pharmacokinetic profiles. Additionally, these products have synergistic effects that allow for multi-target treatment, which should drive market growth.

Industry participants are also combining technology to monitor and track medicinal device combination products, as well as launching high-end products that use sophisticated active ingredients, formulations, delivery methods, and dosage forms like liposomes and transdermal & peptides. They are also focusing on developing new classes of biologics and next-generation products with high viscosity to help patients better adhere to their therapy. As a result, demand for these products is expected to increase.

Furthermore, expanding healthcare infrastructure and improvements in drug delivery technologies are expected to support market expansion. However, strict regulatory guidelines, product recalls, and issues related to certain drug-device combinations may hamper industry growth.

Segment Analysis:

The market for drug-device combinations worldwide is categorized by product types including auto-injectors, microneedle patches, digital pills, smart inhalers, drug delivery hydrogels, and other similar items. The leading product in this market is expected to be the auto-injector in 2022 due to the increase in demand for medical devices to treat patients worldwide.

The global market for drug-device combinations is further divided into various applications such as orthopedic disorders, respiratory diseases, diabetes, cancer, cardiovascular diseases, and other illnesses. The orthopedic segment is predicted to dominate the worldwide drug-device combination market in 2022 as there is a growing elderly population and an increasing requirement for orthopedic medical equipment to treat patients with bone ailments worldwide.

The market for drug-device combinations is segmented by end-users, including hospitals, home care settings, clinics, ambulatory care centers, and others. In 2022, clinics are expected to rule the global market for drug-device combinations as they have access to specialist doctors in developing nations who can diagnose illnesses and recommend effective, prolonged treatments.

Geographical Analysis

Based on geography Drug-Device combination products market has been segmented into five main regions namely North America, Asia Pacific, Europe, South America, and the Middle East & Africa.

North America is predicted to have a significant market share due to the adoption of drug-device combinations and the strong healthcare infrastructure in the area. This is because well-known companies conduct considerable new product development operations in the region. The clinical urgency to use these products to treat chronic diseases is one of the main potential growth factors. This urgency is expected to contribute to the expansion of the North American market.

The United States is expected to account for a large portion of the global market for drug-device combination products due to the rising geriatric population. For example, Breyna, the first approved generic counterpart of AstraZeneca’s Symbicort, was granted FDA clearance in March 2022 after Viatris Inc. submitted its Abbreviated New Drug Application (ANDA). Breyna, a drug-device combination treatment recommended for individuals with asthma or chronic obstructive pulmonary disease (COPD), is expected to fuel market expansion in the US because of the increased use of such devices for controlled medication delivery.

The Asia-Pacific region is expected to grow at a profitable pace over the forecast period. This growth is linked to rising healthcare costs and increasing physician awareness of the benefits of drug-device combination products, including low dosage requirements, timed medication release, direct device-centered infection mitigation using anti-infective medicine in combined effect, and lower systemic exposure. The two primary market drivers are high R&D expenditures by key competitors in the global market and an increase in the commercialization of these systems.

geographical analysis

The report offers the revenue of the global drug-device combination products market for the period 2020-2030, considering 2020 & 2021 as historical years, 2022 as the base year, and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global drug-device combination products market for the forecast period. The global drug-device combination products market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global drug-device combination products market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global drug-device combination products market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the global drug-device combination products market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have also been studied to understand the global drug-device combination products market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the global drug-device combination products market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the global drug-device combination products market. The subsequent section of the Drug-Device Combination Products reports highlights the USPs, which include key industry events (product launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenarios.

Global Drug-Device Combination Products Market Competitive Landscape

The “global drug-device combination products market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as,

  • Medtronic
  • Zimmer Biomet
  • Amgen Inc.
  • Mediprint
  • Propeller Health
  • Ypsomed
  • CosMED Pharmaceutical Co.Ltd.
  • Micron Biomedical, Inc.
  • Findair Sp. z o. o.
  • MetP Pharma AG
  • Eitan Medical
  • Vaxess Technologies Inc.
  • Subcuject Aps
  • E3D Elcam Drug Delivery Devices
  • OcuMedic
  • GlaxoSmithKline plc
  • Bayer AG
  • NanoPass
  • Sensirion AG Switzerland
  • Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Sevices, Inc.)
  • Insulet Corporation
  • TheraJect
  • Otsuka America Pharmaceutical Inc.
  • Raphas Co., Ltd.

The report explores the competitive scenario of the global drug-device combination products market. Major players operating in the global drug-device combination products market have been identified and profiled for unique commercial attributes. Company overview (company description, product portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the Global Drug-Device Combination Products Market report.


Global Drug-Device Combination Products Market, By Products

  • Auto-injector
  • Microneedle patch
  • Digital Pill
  • Smart inhaler
  • Drug delivery hydrogels
  • Drug-eluting lens
  • Others

Global Drug-Device Combination Products Market, By Application

  • Orthopedic diseases
  • Respiratory diseases
  • Diabetes
  • Oncology
  • Cardiovascular diseases
  • Others

Global Drug-Device Combination Products Market, By End-User

  • Clinics
  • Hospitals
  • Home care settings
  • Ambulatory Care Centers
  • Others

Global Drug-Device Combination Products Market, by Region

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • The U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.





Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.



Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:



Market Size

US$ 190.1 billion (2030)

Compound Annual Growth Rate (CAGR)


Base Year


Forecast Period


Forecast Units

Value (US$ Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

Medtronic, Zimmer Biomet, Amgen Inc., Mediprint, Propeller Health, Ypsomed, CosMED Pharmaceutical Co. Ltd

Key Questions Answered in Drug-Device Combination Products Market Report

Medtronic, Zimmer Biomet, Amgen Inc., Mediprint, Propeller Health, Ypsomed, CosMED Pharmaceutical Co. Ltd

Trend: Increased public awareness and disease diagnosis. Drivers: technological advancement in the healthcare & device segment.  Opportunities: Collaboration & partnership by major market players, Challenges: Competition from local & domestic brands, strict regulatory framework & complications associated with drug-device combination.

North America


Investment in research & development activities, new market initiatives & joint ventures, etc.

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert